Pradimicin therapy of disseminated Candida tropicalis infection in the mouse

M. I. Restrepo, L. K. Najvar, A. W. Fothergill, J. R. Graybill

Producción científica: Articlerevisión exhaustiva

5 Citas (Scopus)

Resumen

BMS 181184 (BMS), an analogue of pradimicin, was administered intravenously to neutropenic mice infected with either a fluconazole- susceptible or a fluconazole-resistant clinical isolate of Candida tropicalis. BMS prolonged survival at doses >3 mg kg-1 day-1, and at higher doses reduced tissue counts in mice. BMS was less potent mg for mg than amphotericin B. Combined BMS and amphotericin B were no more effective than either of the individual drugs.

Idioma originalEnglish (US)
Páginas (desde-hasta)181-184
Número de páginas4
PublicaciónMedical mycology
Volumen36
N.º3
DOI
EstadoPublished - jun 1998

ASJC Scopus subject areas

  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'Pradimicin therapy of disseminated Candida tropicalis infection in the mouse'. En conjunto forman una huella única.

Citar esto